AAOS Management of osteoarthritis of the hip: evidence-based clinical practice guideline

AAOS Management of osteoarthritis of the hip: evidence-based clinical practice guideline - American Academy of Orthopaedic Surgeons (AAOS)

Overview: This clinical practice guideline is based on a systematic review of published studies examining the treatment of osteoarthritis (OA) of the hip in adults. It provides recommendations that will help practitioners integrate the current evidence and clinical practice. It also highlights gaps in the literature in need of future research. This guideline is intended to be used by trained physicians and clinicians who manage the surgical and non-surgical treatment of OA of the hip. It also serves as an informational resource for developers and applied users of clinical practice guidelines.

Goals and rationale: The purpose of this clinical practice guideline is to evaluate the current best evidence associated with treatment. vidence-based medicine (EBM) standards advocate for use of empirical evidence by physicians in their clinical decision making. To assist with access to the large resources of information, a systematic review of the literature in publication was conducted between August 2022 and August 2023. It highlights where there is good evidence, where evidence is lacking, and what topics future research will need to target to help facilitate evidence-based decision making in the treatment of patients with OA of the hip. AAOS staff methodologists assisted the physician/clinician work group in evaluating the existing literature so that they could formulate the following recommendations based on a rigorous systematic process. Musculoskeletal care is provided in many different settings and by a variety of providers. We created this guideline as an educational tool to guide qualified physicians and clinicians in making treatment decisions that improve the quality and efficacy of care. This guideline should not be construed as including all possible methods of care or excluding acceptable interventions similarly directed at obtaining favorable outcomes. The final decision to use a specific procedure must be made after assessing all concerns presented by the patient and consideration of locality-specific resources.

Scope: The scope of this guideline includes non-surgical treatment and surgical treatment with total hip arthroplasty of symptomatic OA of the hip. It does not provide recommendations for patients diagnosed with rheumatoid arthritis, OA of other joints, hip dysplasia, or other inflammatory arthropathies. It does not provide recommendations for surgical interventions less invasive than total hip arthroplasty.


Read full guideline